切换至 "中华医学电子期刊资源库"

中华细胞与干细胞杂志(电子版) ›› 2019, Vol. 09 ›› Issue (01) : 35 -39. doi: 10.3877/cma.j.issn.2095-1221.2019.01.007

所属专题: 文献

论著

hUC-MSCs下调HIF-1α及VEGF表达对NAFLD大鼠肝脏损伤的作用
王文清1,(), 易文城1, 林拥华1   
  1. 1. 362000 泉州,福建医科大学附属第二医院普通外科
  • 收稿日期:2018-12-11 出版日期:2019-02-01
  • 通信作者: 王文清

Human umbilical cord mesenchymal stem cells improve liver damage of non-alcoholic fatty liver disease rats by down regulating HIF-1α/VEGF pathway

Wenqing Wang1,(), Wencheng Yi1, Yonghua Lin1   

  1. 1. Department of General Surgery, the Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China
  • Received:2018-12-11 Published:2019-02-01
  • Corresponding author: Wenqing Wang
  • About author:
    Corresponding author: Wang Wenqing, Email:
引用本文:

王文清, 易文城, 林拥华. hUC-MSCs下调HIF-1α及VEGF表达对NAFLD大鼠肝脏损伤的作用[J/OL]. 中华细胞与干细胞杂志(电子版), 2019, 09(01): 35-39.

Wenqing Wang, Wencheng Yi, Yonghua Lin. Human umbilical cord mesenchymal stem cells improve liver damage of non-alcoholic fatty liver disease rats by down regulating HIF-1α/VEGF pathway[J/OL]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2019, 09(01): 35-39.

目的

探讨脐带间充质干细胞(hUC-MSCs)介导HIF-1α/VEGF通路对非酒精性脂肪性肝病(NAFLD)大鼠肝脏损伤的作用。

方法

SD大鼠随机分为正常对照组(NC组)、模型对照组(MC组)和MC+hUC-MSCs组。每组鼠数为7只,分别喂食不同饲料和治疗8周。检测大鼠谷丙转氨酶(ALT)、谷草转氨酶(AST)和胰岛素抵抗指数(HOMA-IR)。光镜观察大鼠肝脏组织病理改变,计算NAFLD活动度积分(NAS);Western Blot法检测大鼠肝脏组织HIF-?1α和VEGF蛋白表达。组间比较采用单因素方差分析、相关分析选用pearson。

结果

(1)治疗末,NC组ALT、AST和HOMA-IR分别为(41.1±5.9)U/L,(51.7±5.2)U/L,(1.93±0.22)?U/?L低于MC组(153.9±7.1)U/L,(169.8±15.9)U/L,(23.20±2.63)U/L差异具有统计学意义(P?< 0.05);与MC组比较,MC+hUC-MSCs组大鼠ALT、AST和HOMA-IR降低分别为(90.7±8.1)?U/?L,(110.0±13.1)U/L,(8.43±1.39)U/L差异具有统计学意义(P?< 0.05)。(2)光镜下NC组肝细胞形态正常;MC组肝细胞呈现脂肪变性,较多细胞核变形,肝小叶排列不齐伴炎症细胞浸润;以上肝组织病理改变在MC+hUC-MSCs组明显改善。与NC组比较,MC组大鼠NAS积分增高;与MC组比较,MC+hUC-MSCs组大鼠NAS积分降低[(0.42 ±0.23)分vs (9.15±0.41)?分、(5.15±0.29)分]。(3)Western Blot法检测肝脏组织HIF-1α和VEGF蛋白表达改变:与NC组比较,MC组大鼠HIF-1α和VEGF蛋白表达均增高(P均< 0.05);与MC组比较,MC+hUC-?MSCs组大鼠HIF-1α和VEGF蛋白表达均降低(P均< 0.05)。单因素相关分析显示大鼠肝脏组织HIF-?1α表达与HOMA-IR指数呈正相关(P均< 0.05)。而且,大鼠肝脏组织NAS评分与肝脏组织HIF-?1α、VEGF表达亦呈正相关(r值分别为0.901、0.874,P均< 0.05)。

结论

?hUC-?MSCs对高糖高脂饲料喂养诱导的NAFLD大鼠受损肝脏功能具有改善作用,其机制与其下调HIF-?1α/?VEGF通路相关。

Objective

To evaluate the protective effect of human umbilical cord mesenchymal stem cells on non-alcoholic fatty liver disease and its relationship with HIF-1α/?VEGF mechanism in rats.

Methods

Rats were divided randomly into three groups: normal control (NC) , non-alcoholic fatty liver disease model (MC) and hUC-MSCs treatment group (MC+hUC-?MSCs) . The number of each group was eight, the rats of each group were fed different diets and received 8 weeks' intervention. At the end of treatment, ALT, AST and HOMA-IR were measured respectively. The pathologyical changes of liver tissue were observed by light microscope. Then NAS was calculated. The expression of HIF-1α and VEGF protein in liver tissues were detected by Western Blot.

Results

(1) At the end of treatment, compared with the NC group, the values of ALT, AST and HOMA-IR in the MC group were significantly raised (P < 0.05) . MC, ALT, AST and HOMA-?IR were significantly reduced in the MC+hUC-MSCs group. (2) By light microscope: The hepatocyte morphology was normal in NC group. The hepatocyte showed marked steatosis, more nuclear deformation, the lobules were misaligned with inflammatory cell infiltration in the MC group. The above liver histopathological changes were improved in the hUC-MSCs group. Compared with NC group, NAS was increased in the MC group, which could be reversed by hUC-MSCs[ (0.42?± 0.23) vs (9.15±0.41) , (5.15±0.29) ]. (3) Compared with the NC group, the HIF-1α and VEGF protein expression by Western Blot in the liver tissues were significantly raised respectively. Compared with the MC group, the expressions indexes of HIF-1α and VEGF were reversed in the hUC-MSCs group (P < 0.05) . Single factor correlation analysis showed that HIF-1α protein level of of the liver tissues was dependent on HOMA-IR. Further, NAS score was dependent on HIF-1α and VEGF expression (r = 0.901、0.874, P < 0.05) .

Conclusions

Human umbilical cord mesenchymal stem cells can improve liver damage of non-alcoholic fatty liver disease rats. The effects may be related to down regulating HIF-1α /VEGF pathway.

表1 各组大鼠治疗8周ALT、AST和HOMA-IR比较( ± s)
图1 光镜下观察各组大鼠治疗8周肝脏组织病理改变(HE染色,×200)
图2 各组大鼠治疗8周Western Blot法检测肝脏组织VEGF、HIF-1α和GAPDH蛋白表达水平
图3 各组大鼠治疗8周Western Blot法检测肝脏组织HIF-?1α和VEGF相对蛋白表达
[1]
Younossi ZM,Stepanova M,Afendy M, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008[J]. Clin Gastroenterol Hepatol, 2011, 9(6): 524-530.
[2]
Angulo P,Keach JC,Batts KP,et a1. IndepeIndent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis[J]. Hepatology, 1999, 30(6):1356-1362.
[3]
Li HE,Wu CY. Research progress on the protective effect of scutellarin in cerebral ischemia[J]. Chin J Neuroanat, 2017, 2(33):237-240.
[4]
Rosenberger C,Rosen S,Shina A, et al. Activation of hypoxia inducible factors ameliorates hypoxic distal tubular injury in the isolated perfused rat kidney[J]. Nephrol Dial Transplant, 2008, 23(11):3472-3478.
[5]
Guo H,Zhou H,Lu J, et al. Vascular endothelial growth factor: an attractive target in the treatment of hypoxic/ischemic brain injury[J].Neural Regen Res, 2016, 11(1):174-179.
[6]
Cho KA,Ju SY,Cho SJ, et al. Mesenchymal stem cells showed the highest potential for the regeneration of injured liver tissue compared with other subpopulations of the bone marrow[J]. Cell Biol Int, 2009, 33(7):772-777.
[7]
Lee KD,Kuo TK,Whang-Peng J, et al. In vitro hepatic differentiation of human mesenchymal stem cells[J]. Hepatology, 2004, 40(6):1275-1284.
[8]
Kuroda Y,Kitada M,Wakao S, et al. Bone marrow mesenchymal cells: how do they contribute to tissue repair and are they really stem cells?[J]. Arch Immunol Ther Exp (Warsz), 2011, 59(5):369-378.
[9]
Zeyda M,Stulnig TM. Obesity, inflammation, and insulin resistance-a mini-review[J]. Gerontology, 2009, 55(4):379-386.
[1] 樊恒, 孙敏, 朱建华. 红景天苷通过抑制PI3K/AKT/mTOR信号通路对大鼠脓毒症急性肾损伤的保护作用[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(03): 188-195.
[2] 唐丹, 姚晓曦, 杨博文, 薛绍龙, 李梦瑶, 韦柳杏, 郄明蓉. 双肾上腺皮质激素样激酶1对子宫内膜样腺癌患者临床特征的影响[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 582-590.
[3] 邵小丽, 林燕, 张玲玲, 韩亚琴. 超声引导下子宫肌瘤注射聚桂醇硬化术联合术后米非司酮治疗临床疗效分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 353-360.
[4] 黄福, 王黔, 金相任, 唐云川. VEGFR2、miR-27a-5p在胃癌组织中的表达与临床病理参数及预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 558-561.
[5] 朱佳琳, 方向, 贵诗雨, 黄丹, 周小雨, 郭文恺. 大鼠切口疝腹膜前间隙补片修补术后血清中VEGF 和Ang-1 的表达情况[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 703-707.
[6] 张敏龙, 杨翠平, 王博, 崔云杰, 金发光. MiR-200b-3p 通过抑制HIF-1α 表达减轻海水吸入诱导的肺水肿作用及机制[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 696-700.
[7] 李智, 冯芸. NF-κB 与MAPK 信号通路及其潜在治疗靶点在急性呼吸窘迫综合征中的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 840-843.
[8] 张敏, 朱建华, 缪雅芳, 郭锦荣. 菝葜皂苷元对肝癌HepG2细胞抑制作用的机制研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 328-335.
[9] 季加翠, 孙春斌, 罗恩丽. 姜黄素通过调节NF-κB/NLRP3通路减轻LPS诱导小胶质细胞神经炎症损伤[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(04): 193-203.
[10] 李博, 马秀岩, 孙杰. lncRNA TINCR对滋养层HTR-8/SVneo细胞生物学行为的影响及其机制[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(03): 167-172.
[11] 梁国豪, 张茜, 张研. 间充质干细胞及其衍生物治疗高原低氧环境下心血管疾病的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(02): 107-112.
[12] 阿卜杜萨拉木·图尔荪麦麦提, 吐尔洪江·吐逊, 温浩. 肝脏缺血-再灌注损伤与cGAS-STING信号通路[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 394-397.
[13] 靳英, 付小霞, 陈美茹, 袁璐, 郝力瑶. CD147调控MAPK信号通路对结肠癌细胞增殖和凋亡的影响及机制研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 474-480.
[14] 陈秋怡, 林熙, 刘珍银. 淋巴管畸形分子机制的研究进展[J/OL]. 中华介入放射学电子杂志, 2024, 12(04): 374-379.
[15] 李娟, 廖江涛, 吴聃. 老年人结直肠腺瘤与血脂及非酒精性脂肪肝的相关性研究[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(03): 186-190.
阅读次数
全文


摘要